Company intelligence / Profile preview

Tikkun Capital

Tel Aviv-Yafo, Israel

Ownership: Private
Employees: ~19
Development stage: Other

Overview

Tikun Olam-Cannbit Pharmaceuticals produces medical cannabis products utilized for a wide range of indications, with an established regulatory track record and global pharmaceutical collaborations.[3][4]

Therapeutic areas: OncologyNeurologyImmunology
Modalities: BiologicSmall molecule
Industry: Biotech

Partnerships

Wavelength (SK Capital Partners portfolio company)[3]Ongoing clinical collaborations in Israel[2]

Beyond the preview

Go deeper on Tikkun Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tikkun Capital.

Explore the full profile